Wellgistics Health Inc (WGRX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access WGRX Annual Cash Flow →
Cash flow patterns shown here provide context for understanding Wellgistics Health Inc's ability to sustain operations and capital deployment.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
6 Months
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income-26.11
Depreciation & amortization0.77
Amortization of Other Assets0.66
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Goodwill, Impairment Loss0.00
Provision For Loan Losses Expensed0.21
Increase (Decrease) in Inventories0.02
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation2.56
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt-8.88
Increase Decrease In Operating Lease Liability-0.01
Write Off Of Other Assets-
Licence Acquired Through Accounts Payable-
Issuance Of Commitment Shares Under Equity Purchase Agreement-
Derecognition Of Promissory Note And Accrued Interest Pursuant To Debt Extinguishment-
Common Stock Ssued In Partial Settlement Of Sellers Note-
Amortization Of Debt Discount1.49
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.25
Increase (Decrease) in Accounts Payable2.43
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities2.64
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.41
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities18.73
Discontinued operations0.00
Net Cash flow from Operating Activities-6.31
Investing Activities
Capital Expenditures-0.45
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payments Deposits Paid For Operating Leases-
Payment For Contingent Consideration Liability Investing Activities-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Cash Acquired from Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.45
Financing Activities
Short-term debt Net-3.75
Other borrowing transactions0.00
Long-term debt - borrowings14.20
Long-term debt - repayments-0.04
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-1.16
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.09
Proceeds From Merchant Cash Advance-
Proceeds From Common Stock Issued To Founders-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations0.04
Proceeds From Issuance Offering Costs-
Proceeds From Common Stock Issued Pursuant To Public Offering-
Repayment Of Seller Promissory Note-
Repayments Of Revolving Line Of Credit-0.14
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities9.17
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-6.75
Total Cash Flow2.41
4 historic quarters locked

Sign in to unlock the full Wellgistics Health Inc cash flow history.

About Datameds Ai Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 17, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001493152-26-038581

Figures are derived from filed reports and may be restated. Historical data is subject to revision.